La mastectomía bilateral con reconstrucción inmediata en pacientes con cáncer de mama ¿retrasa el inicio de terapias adyuvantes? / Bilateral mastectomy with immediate reconstruction as a treatment for breast cancer: is it the cause of delays in adjuvant therapies?

Resumen Introducción El tratamiento estándar del cáncer de mama es la cirugía conservadora, aunque actualmente existe un incremento de cirugías más radicales, incluyendo reconstrucción. Estas técnicas, aparentemente más complejas, pueden suponer mayor índice de complicaciones y, por ende, mayor intervalo de tiempo entre la cirugía y el inicio de terapias adyuvantes, lo que puede condicionar peores resultados de los tratamientos, traducido en el índice de recidivas locales y/o sistémicas o incluso de las tasas de supervivencia. Objetivo Revisar si la mastectomía bilateral con reconstrucción inmediata (MBRI) supone un retraso en el inicio del tratamiento adyuvante (TA). Materiales y Método Análisis retrospectivo de pacientes con MBRI como tratamiento de cáncer. Variables principales: tiempo transcurrido entre la cirugía y el inicio de la TA, definiendo retraso como más de 90 días. Otras variables: datos del paciente, tipo de intervención, complicaciones. Se analizan datos por tipo de intervención y si presentaban cirugía conservadora previa. Resultados 296 pacientes con MBRI, 171 (57,7%) por cáncer de novo y 125 (42,3%) por neoplasia recidivada o un segundo primario (ipsi o contralateral). La tasa general de complicaciones fue de 21% y no difirió entre los grupos con y sin radioterapia previa (p 0,05). La técnica quirúrgica asociada a una tasa mayor de complicaciones fue el patrón corto de Wise. No hubo diferencias en el resto. No existió un retraso significativo mayor de 90 días en los grupos con o sin radioterapia, ni según la técnica quirúrgica. Conclusiones La MBRI no ocasiona retrasos significativos en el inicio de TA.

Background Breast conserving surgery is already the standard treatment of breast cancer although mastectomy and radical techniques including reconstruction are currently increasing. These techniques, apparently more complex, can develop more complications and delay adjuvant therapies initiation, conditioning worst results of treatments, with higher rates of local and/or systemic recurrences or even survival rates. Aim Review whether bilateral mastectomy with immediate reconstruction (MBRI) conditionate a delay in the initiation of adjuvant therapy (TA). Materials and Method A retrospective analysis of patients with MBRI as a cancer treatment. Main variable: Time to TA, was defined as the number of days between surgery and the first dose of chemotherapy or radiotherapy. Other variables: patient data, type of intervention and complications. We analyzed the data by type of intervention and if they had been previously treated from another breast tumor. Results In all, 296 patients with MBRI were included, 171 with a Cancer de novo and 125 already treated that now have a relapsed neoplasia or a second primary (IPSI or contralateral). Overall complication rate was 21%. Complication rate did not differ between groups either or neither previous radiotherapy. The surgical technique associated with a higher rate of complications was the short Wise pattern, with no differences in the others. There was no delay greater than 90 days in the groups with radiotherapy or without, or according to the surgical technique. Conclusions MBRI does not cause significant delays in the beginning of adjuvant therapies.

Incidental Detection of Ductal Carcinoma In Situ of the Breast from Bilateral Prophylactic Mastectomy of Asymptomatic BRCA2 Mutation Carrier: A Case Report / 한국유방암학회지

In women at high-risk for breast cancer with a BRCA mutation, bilateral prophylactic mastectomy (BPM) may achieve a risk reduction. A 35-year-old woman had a strong family history of breast and ovarian cancer. She had a regular checkup and found masses in both breasts that confirmed intraductal papillomas and atypical ductal hyperplasia after vacuum assisted mass excision. When she was referred to our clinic, the genetic testing for BRCA mutation was recommended to her sister that managed for ovarian cancer. It was resulted in the positive for the BRCA2 mutation, so she had checked the genetic testing which resulted in the same as the mutation. After sufficient counseling, she decided to undergo BPM and immediate reconstruction. She is satisfied with the result of surgery. This is the first report of BPM of asymptomatic BRCA2 mutation carrier in Korea and BPM should be considered as a risk-reducing option for BRCA mutation carriers.

Mondor's Disease after Bilateral Mastectomy in Both Breast Paraffinoma Patient

PURPOSE: Mondor's disease is a rare benign condition which involves thrombophlebitis of the superficial veins of the breast and anterior chest wall after breast surgery, breast tissue biopsy, inflammatory reaction, breast cancer, trauma. The affected veins include the lateral thoracic, axillary veins, thoracoepigastric veins and superior epigastric veins. METHODS: A 49-year-old woman presented to the outpatient department with complaints of the sudden appearance of a subcutaneous cord just under the skin at left lower lateral abdominal wall 1 month later of bilateral mastectomy due to both severe breast paraffinoma. The cord was initially red and tender and subsequently became a painless, tough, fibrous band that was accompanied by tension and skin retraction. RESULTS: On ultrasonographic findings, palpable threadlike structures at both lateral superficial abdominal wall after bilateral mastectomy were noted. Superficial short elongated hypoechoic tubular structures were noted just under the skin at palpable lower lateral abdominal wall. It was compatible to Mondor's disease of thoracoepigastric vein. CONCLUSION: The increase in breast surgery will give rise to the increase in the frequency of Mondor's disease clinically. Mondor's disease can be diagnosed with clinical symptoms and image findings and the disease has proved to be benign and self-limited.

Mondor's Disease after Bilateral Mastectomy in Both Breast Paraffinoma Patient

PURPOSE: Mondor's disease is a rare benign condition which involves thrombophlebitis of the superficial veins of the breast and anterior chest wall after breast surgery, breast tissue biopsy, inflammatory reaction, breast cancer, trauma. The affected veins include the lateral thoracic, axillary veins, thoracoepigastric veins and superior epigastric veins. METHODS: A 49-year-old woman presented to the outpatient department with complaints of the sudden appearance of a subcutaneous cord just under the skin at left lower lateral abdominal wall 1 month later of bilateral mastectomy due to both severe breast paraffinoma. The cord was initially red and tender and subsequently became a painless, tough, fibrous band that was accompanied by tension and skin retraction. RESULTS: On ultrasonographic findings, palpable threadlike structures at both lateral superficial abdominal wall after bilateral mastectomy were noted. Superficial short elongated hypoechoic tubular structures were noted just under the skin at palpable lower lateral abdominal wall. It was compatible to Mondor's disease of thoracoepigastric vein. CONCLUSION: The increase in breast surgery will give rise to the increase in the frequency of Mondor's disease clinically. Mondor's disease can be diagnosed with clinical symptoms and image findings and the disease has proved to be benign and self-limited.